11 portfolio companies from across our platform have been named in CB Insight's Digital Health 150. The Digital Health 150 is CB Insights' annual ranking of the 150 most promising digital health startups in the world.
Five companies from the Eight Roads global portfolio including Insilico, Medbanks, Meditrust, Owkin and Pharmeasy and six companies from our U.S based sister fund F-Prime Capital have been named - Devoted Health, Firefly Health, Iora Health, Notable, Quartet Health and Protenus. We are thrilled for these companies and are grateful for the opportunity to work alongside such talented founders and teams.
The companies included in the ranking are located across 18 countries around the world that are reimagining the lines of the traditional healthcare experience across 12 overarching categories. The companies have been selected from close to 8,000 startups based on several factors including patent activity, business relations, investor profile, news sentiment analysis, proprietary Mosaic scores, market potential, competitive landscape, team strength, and tech novelty.
Here are some insights from the Digital Health Industry:
- The 2020 Digital Health 150 startups have raised over $20B in total funding across 600+ deals from 900+ unique investors (as of 8/10/2020)
- Demand for telehealth services has skyrocketed amid the global Covid-19 pandemic. As a result, many brick-and-mortar platforms have recently added telehealth offerings. On this year’s list, a total of 62 startups — 41% of the selected companies — offer remote healthcare services
- Optimization of healthcare costs is a growing priority for all stakeholders — from patients and providers to plan sponsors and health plans. As a result, administrative workflow solutions along with private health insurers are on the rise
- Women’s health is growing from a nascent market into an increasingly comprehensive one as more products and services are developed for women of all life stages and experiences